Evelo Biosciences Inc. (EVLO), which touched $6.82 in early trading, up 23% from the previous day's close, is one of the top gainers of the day as the Company continues to build on the momentum, with multiple clinical readouts planned across its inflammation and oncology portfolio this year.
from RTT - Biotech https://ift.tt/2wwN3HZ
via IFTTT
No comments:
Post a Comment